Jennifer Goldsack, CEO, DiMe Society, shares her thoughts on challenges facing the digital biomarkers industry, and the steps DiMe Society are taking to reshape healthcare.

Click Here to Download Your Copy

Recent News

Q&A: Benjamin Vandendriessche, Byteflies

Read more +

Q&A: Anders Strömberg, Sony

Read more +

Q&A: Lucy Cesnakova, DiMe Society

Read more +